GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Financial Statements

7 Followers

GlaxoSmithKline Pharmaceuticals Limited Financial Overview

GlaxoSmithKline Pharmaceuticals Limited's market cap is currently ₹404.75B. The company's EPS TTM is ₹56.39; its P/E ratio is 37.33; and it has a dividend yield of 2.16%. GlaxoSmithKline Pharmaceuticals Limited is scheduled to report earnings on May 13, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 38.22B	₹ 37.26B	₹ 34.42B	₹ 32.26B	₹ 32.64B
Gross Profit	₹ 17.97B	₹ 22.53B	₹ 20.22B	₹ 18.68B	₹ 18.14B
Operating Income	₹ 12.43B	₹ 11.14B	₹ 8.38B	₹ 7.48B	₹ 6.99B
EBITDA	₹ 13.09B	₹ 13.28B	₹ 8.88B	₹ 9.04B	₹ 8.49B
Net Income	₹ 10.36B	₹ 9.28B	₹ 5.90B	₹ 6.11B	₹ 16.95B
Balance Sheet
Cash & Short-Term Investments	₹ 27.82B	₹ 24.98B	₹ 18.57B	₹ 16.54B	₹ 29.03B
Total Assets	₹ 43.24B	₹ 41.08B	₹ 35.57B	₹ 33.27B	₹ 46.33B
Total Debt	₹ 332.70M	₹ 99.50M	₹ 186.65M	₹ 155.40M	₹ 200.76M
Net Debt	₹ -13.58B	₹ -13.94B	₹ -455.06M	₹ -194.00M	₹ -2.66B
Total Liabilities	₹ 20.56B	₹ 21.57B	₹ 17.79B	₹ 15.85B	₹ 19.70B
Stockholders' Equity	₹ 22.67B	₹ 19.51B	₹ 17.78B	₹ 17.41B	₹ 26.63B
Cash Flow
Free Cash Flow	₹ 9.67B	₹ 12.67B	₹ 5.51B	₹ 4.40B	₹ 7.76B
Operating Cash Flow	₹ 10.22B	₹ 12.90B	₹ 5.82B	₹ 4.84B	₹ 8.11B
Investing Cash Flow	₹ 2.78B	₹ -458.10M	₹ 87.12M	₹ 8.08B	₹ -4.06B
Financing Cash Flow	₹ -7.37B	₹ -7.69B	₹ -5.61B	₹ -15.43B	₹ -5.24B

Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History

Income Statement >

GlaxoSmithKline Pharmaceuticals Limited Debt to Assets

Balance Sheet >

GlaxoSmithKline Pharmaceuticals Limited Cash Flow

Cash Flow >

GlaxoSmithKline Pharmaceuticals Limited Forecast EPS vs Actual EPS

Earnings >